AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionJT Stratford LLC
Latest Disclosed Ownership8,036 shares
Latest Disclosed Value $ 1,747,750
JT Stratford LLC reports 1.54% increase in ownership of 4AB / AbbVie Inc.

On May 15, 2026 - JT Stratford LLC filed a 13F-HR form disclosing ownership of 8,036 shares of AbbVie Inc. (BG:4AB) valued at $1,747,750 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 7,914 shares of AbbVie Inc.. This represents a change in shares of 1.54% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBVIE COM 00287Y109 8,036 122 1.54 1,748 -3.37 0.2225
2026-02-12 2025-12-31 13F ABBVIE COM 00287Y109 7,914 -5 -0.06 1,808 -1.36 0.2321
2025-11-12 2025-09-30 13F ABBVIE COM 00287Y109 7,919 571 7.77 1,834 34.48 0.2456
2025-08-13 2025-06-30 13F ABBVIE COM 00287Y109 7,348 212 2.97 1,364 -8.83 0.2064
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 7,136 88 1.25 1,495 19.41 0.2643
2025-02-18 2024-12-31 13F ABBVIE COM 00287Y109 7,048 -59 -0.83 1,252 -10.76 0.2059
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 7,107 536 8.16 1,403 24.49 0.2400
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 6,571 276 4.38 1,127 -1.66 0.2094
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 6,295 55 0.88 1,146 18.51 0.2283
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 6,240 -3,676 -37.07 967 -34.57 0.2212
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 9,916 1,571 18.83 1,478 31.49 0.3814
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 8,345 429 5.42 1,124 -10.86 0.3026
2023-05-10 2023-03-31 13F ABBVIE COM 00287Y109 7,916 1,144 16.89 1,262 15.27 0.3626
2023-02-14 2022-12-31 13F ABBVIE COM 00287Y109 6,772 153 2.31 1,094 23.20 0.3499
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 6,619 -519 -7.27 888 -18.76 0.3158
2022-08-15 2022-06-30 13F ABBVIE COM 00287Y109 7,138 -2,312 -24.47 1,093 -28.66 0.3462
2022-05-12 2022-03-31 13F ABBVIE COM 00287Y109 9,450 -801 -7.81 1,532 10.37 0.4478
2022-02-11 2021-12-31 13F ABBVIE COM 00287Y109 10,251 -149 -1.43 1,388 23.71 0.3800
2021-11-15 2021-09-30 13F ABBVIE COM 00287Y109 10,400 -49 -0.47 1,122 -4.67 0.3444
2021-08-16 2021-06-30 13F ABBVIE COM 00287Y109 10,449 573 5.80 1,177 10.10 0.3764
2021-05-12 2021-03-31 13F ABBVIE COM 00287Y109 9,876 1,185 13.63 1,069 14.82 0.3768
2021-02-16 2020-12-31 13F ABBVIE COM 00287Y109 8,691 -46 -0.53 931 21.70 0.3489
2020-11-13 2020-09-30 13F ABBVIE COM 00287Y109 8,737 -1,455 -14.28 765 -23.58 0.3298
2020-08-14 2020-06-30 13F ABBVIE COM 00287Y109 10,192 1,640 19.18 1,001 53.53 0.5153
2020-05-14 2020-03-31 13F ABBVIE COM 00287Y109 8,552 2,988 53.70 652 32.25 0.3993
2020-02-14 2019-12-31 13F ABBVIE COM 00287Y109 5,564 -913 -14.10 493 0.61 0.2258
2019-11-19 2019-09-30 13F ABBVIE COM 00287Y109 6,477 1,548 31.41 490 36.87 0.2756
2019-08-14 2019-06-30 13F ABBVIE COM 00287Y109 4,929 -232 -4.50 358 -13.94 0.1986
2019-05-15 2019-03-31 13F ABBVIE COM 00287Y109 5,161 -1,786 -25.71 416 -35.00 0.2389
2019-02-14 2018-12-31 13F ABBVIE COM 00287Y109 6,947 -585 -7.77 640 -10.11 0.4259
2018-11-14 2018-09-30 13F ABBVIE COM 00287Y109 7,532 -323 -4.11 712 -2.20 0.4084
2018-08-13 2018-06-30 13F ABBVIE COM 00287Y109 7,855 839 11.96 728 9.64 0.4482
2018-05-14 2018-03-31 13F ABBVIE COM 00287Y109 7,016 440 6.69 664 4.40 0.4146
2018-02-15 2017-12-31 13F ABBVIE COM 00287Y109 6,576 650 10.97 636 20.68 0.4150
2017-11-14 2017-09-30 13F ABBVIE COM 00287Y109 5,926 -445 -6.98 527 14.07 0.3412
2017-08-14 2017-06-30 13F ABBVIE COM 00287Y109 6,371 -16,384 -72.00 462 -68.85 0.3250
2017-05-12 2017-03-31 13F ABBVIE COM 00287Y109 22,755 -10,187 -30.92 1,483 -28.11 1.1013
2017-02-09 2016-12-31 13F ABBVIE COM 00287Y109 32,942 32,942 2,063 1.7329
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.